Ammodo Science Award for tuberculosis vaccine
For their pioneering research on tuberculosis, Prof. Adri Minnaard of the Stratingh Institute for Chemistry , Prof. Branch Moody (Harvard University) and Dr. Ildiko van Rhijn (Utrecht University) will receive the Ammodo Science Award for groundbreaking research . Their multidisciplinary 'Lipidomics Team' will use the €1.6 million prize to further develop tests and vaccines against tuberculosis.
The Ammodo Science Award is given to potentially groundbreaking internationally recognised research conducted in teams. The award ceremony will take place this spring at the Rijksakademie van beeldende kunsten (State Academy of fine Arts) in Amsterdam.

Minnaard: "Winning the prize means we can go ahead and explore some bold hypotheses without making them plausible beforehand."
Crucial role lipids
The Lipidomics team has been researching tuberculosis for more than fifteen years. With more than one and a half million deaths every year tuberculosis is the deadliest bacterial infectious disease worldwide. With their research, the team has revealed that tuberculosis bacteria survive in the human body by producing unique lipids. This allows the bacteria to remain dormant in the body for a long time until the immune system is weakened, and the carrier becomes ill. With the research findings, scientists now better understand the infectiousness of tuberculosis.
Mission: good test and vaccine
The Lipidomics Team's mission is to establish a reliable diagnostic test and develop an effective vaccine for tuberculosis. Both are now in development, although it will take several years before they reach the market. Minnaard underlines that winning the prize is important for the research: "It means we can continue and explore some bold hypotheses without making them plausible beforehand."
Fight against other bacterial pathogens
The insights gained by the team will also likely help them map other important bacterial pathogens. The next step is to set up a research programme on newly discovered lipids in the bacteria that cause typhoid fever, blood poisoning and skin infections.
More information
Last modified: | 05 March 2024 11.12 a.m. |
More news
-
03 April 2025
IMChip and MimeCure in top 10 of the national Academic Startup Competition
Prof. Tamalika Banerjee’s startup IMChip and Prof. Erik Frijlink and Dr. Luke van der Koog’s startup MimeCure have made it into the top 10 of the national Academic Startup Competition.
-
01 April 2025
NSC’s electoral reform plan may have unwanted consequences
The new voting system, proposed by minister Uitermark, could jeopardize the fundamental principle of proportional representation, says Davide Grossi, Professor of Collective Decision Making and Computation at the University of Groningen
-
01 April 2025
'Diversity leads to better science'
In addition to her biological research on ageing, Hannah Dugdale also studies disparities relating to diversity in science. Thanks to the latter, she is one of the two 2024 laureates of the Athena Award, an NWO prize for successful and inspiring...